ATP9A
Probable phospholipid-transporting ATPase IIA
Also known as: ATP9A_HUMAN, ATPIIA, KIAA0611
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75110
- Gene
- ATP9A
- Ensembl
- ENSG00000054793
- Chromosome
- 20
- Canonical length
- 1047 aa
- Protein class
- Enzymes, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Enables protease binding activity. Involved in negative regulation of exosomal secretion; regulation of endocytic recycling; and regulation of retrograde transport, endosome to Golgi. Located in several cellular components, including endosome; perinuclear region of cytoplasm; and trans-Golgi network membrane. Implicated in neurodevelopmental disorder with poor growth and behavioral abnormalities. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1047 residues, UniProt reviewed canonical sequence.
>O75110|ATP9A
1 MTDNIPLQPV RQKKRMDSRP RAGCCEWLRC CGGGEARPRT VWLGHPEKRD QRYPRNVINN
61 QKYNFFTFLP GVLFNQFKYF FNLYFLLLAC SQFVPEMRLG ALYTYWVPLG FVLAVTVIRE
121 AVEEIRCYVR DKEVNSQVYS RLTARGTVKV KSSNIQVGDL IIVEKNQRVP ADMIFLRTSE
181 KNGSCFLRTD QLDGETDWKL RLPVACTQRL PTAADLLQIR SYVYAEEPNI DIHNFVGTFT
241 REDSDPPISE SLSIENTLWA GTVVASGTVV GVVLYTGREL RSVMNTSNPR SKIGLFDLEV
301 NCLTKILFGA LVVVSLVMVA LQHFAGRWYL QIIRFLLLFS NIIPISLRVN LDMGKIVYSW
361 VIRRDSKIPG TVVRSSTIPE QLGRISYLLT DKTGTLTQNE MIFKRLHLGT VAYGLDSMDE
421 VQSHIFSIYT QQSQDPPAQK GPTLTTKVRR TMSSRVHEAV KAIALCHNVT PVYESNGVTD
481 QAEAEKQYED SCRVYQASSP DEVALVQWTE SVGLTLVGRD QSSMQLRTPG DQILNFTILQ
541 IFPFTYESKR MGIIVRDEST GEITFYMKGA DVVMAGIVQY NDWLEEECGN MAREGLRVLV
601 VAKKSLAEEQ YQDFEARYVQ AKLSVHDRSL KVATVIESLE MEMELLCLTG VEDQLQADVR
661 PTLETLRNAG IKVWMLTGDK LETATCTAKN AHLVTRNQDI HVFRLVTNRG EAHLELNAFR
721 RKHDCALVIS GDSLEVCLKY YEYEFMELAC QCPAVVCCRC APTQKAQIVR LLQERTGKLT
781 CAVGDGGNDV SMIQESDCGV GVEGKEGKQA SLAADFSITQ FKHLGRLLMV HGRNSYKRSA
841 ALSQFVIHRS LCISTMQAVF SSVFYFASVP LYQGFLIIGY STIYTMFPVF SLVLDKDVKS
901 EVAMLYPELY KDLLKGRPLS YKTFLIWVLI SIYQGSTIMY GALLLFESEF VHIVAISFTS
961 LILTELLMVA LTIQTWHWLM TVAELLSLAC YIASLVFLHE FIDVYFIATL SFLWKVSVIT
1021 LVSCLPLYVL KYLRRRFSPP SYSKLTSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP9A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 88 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 88 nTPM
- basal ganglia: 52 nTPM
- cerebellum: 49 nTPM
- hypothalamus: 44 nTPM
- hippocampal formation: 41 nTPM
- amygdala: 40 nTPM
Single-cell type
- urothelial cells: 286 nCPM
- adipocytes: 275 nCPM
- pancreatic islet cells: 243 nCPM
- salivary ionocytes: 220 nCPM
- foveolar cells: 214 nCPM
- brain excitatory neurons: 187 nCPM
Immune cell
- basophil: 4.4 nTPM
- NK-cell: 1 nTPM
- total PBMC: 0.7 nTPM
- gdT-cell: 0.3 nTPM
- memory CD8 T-cell: 0.3 nTPM
- intermediate monocyte: 0.1 nTPM
Brain region
- cerebral cortex: 217 nTPM
- basal ganglia: 208 nTPM
- hippocampal formation: 200 nTPM
- hypothalamus: 191 nTPM
- midbrain: 189 nTPM
- amygdala: 185 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP9A.
Disease | AllUniProt
Conditions ATP9A is implicated in, by any mechanism.
- Neurodevelopmental disorder with poor growth and behavioral abnormalities (NEDGBA) MIM:620242
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 175 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with poor growth and behavioral abnormalities
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.21
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.15
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endocytosis
- negative regulation of exosomal secretion
- neuron projection morphogenesis
- phospholipid translocation
- regulation of endocytic recycling
- regulation of retrograde transport, endosome to Golgi
- retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATPase-coupled intramembrane lipid transporter activity
- magnesium ion binding
- protease binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- P-type ATPase, subfamily IV
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- P-type ATPase, C-terminal
- P-type ATPase, N-terminal
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P-type ATPase, A domain
- P-type ATPase actuator domain
- haloacid dehalogenase-like hydrolase
- Phospholipid-translocating ATPase N-terminal
- Phospholipid-translocating P-type ATPase C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP9A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP9A as an antibody target. Whether an autoantibody or antibody against ATP9A could matter depends on whether native ATP9A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP9A is annotated at the cell surface, where native ATP9A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP9A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...